{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T18:14:06Z","timestamp":1780078446364,"version":"3.54.0"},"reference-count":39,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T00:00:00Z","timestamp":1559347200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T00:00:00Z","timestamp":1559347200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,4,15]],"date-time":"2019-04-15T00:00:00Z","timestamp":1555286400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["R01 DA030431"],"award-info":[{"award-number":["R01 DA030431"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["R01 DA0414150"],"award-info":[{"award-number":["R01 DA0414150"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journalofsubstanceabusetreatment.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Substance Abuse Treatment"],"published-print":{"date-parts":[[2019,6]]},"DOI":"10.1016\/j.jsat.2019.04.001","type":"journal-article","created":{"date-parts":[[2019,4,4]],"date-time":"2019-04-04T12:07:09Z","timestamp":1554379629000},"page":"72-78","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"special_numbering":"C","title":["The payer's role in addressing the opioid epidemic: It's more than money"],"prefix":"10.1016","volume":"101","author":[{"given":"Todd","family":"Molfenter","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9014-2894","authenticated-orcid":false,"given":"Dennis","family":"McCarty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nora","family":"Jacobson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jee-Seon","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanford","family":"Starr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Zehner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.jsat.2019.04.001_bb0005","doi-asserted-by":"crossref","first-page":"143","DOI":"10.15288\/jsad.2015.76.143","article-title":"Adoption of injectable naltrexone in U.S. substance use disorder treatment programs","volume":"76","author":"Aletraris","year":"2015","journal-title":"Journal of Studies on Alcohol and Drugs"},{"key":"10.1016\/j.jsat.2019.04.001_bb0010","author":"Allen"},{"issue":"1","key":"10.1016\/j.jsat.2019.04.001_bb0015","first-page":"1","article-title":"Training therapists in evidence-based practice: A critical review of studies from a systems-contextual perspective","volume":"17","author":"Beidas","year":"2010","journal-title":"Clinical Psychology"},{"issue":"4","key":"10.1016\/j.jsat.2019.04.001_bb0020","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1097\/ADM.0000000000000310","article-title":"Vermont hub-and-spoke model of care for opioid use disorder: Development, implementation, and impact","volume":"11","author":"Brooklyn","year":"2017","journal-title":"Journal of Addiction Medicine"},{"key":"10.1016\/j.jsat.2019.04.001_bb0025","author":"Centers for Disease Control and Prevention (CDC)"},{"key":"10.1016\/j.jsat.2019.04.001_bb0030","author":"City of Philadelphia"},{"key":"10.1016\/j.jsat.2019.04.001_bb0035","series-title":"Public Law No. 106\u2013310, Title XXXV-Waiver authority for physicians who dispense or prescribe certain narcotic drugs for maintenance treatment or detoxification treatment, Public Law No. 106\u2013310 C.F.R","author":"Drug Addiction Treatment Act of 2000 (DATA 2000)","year":"2000"},{"key":"10.1016\/j.jsat.2019.04.001_bb0040","series-title":"The NIATx model: Process improvement in behavioral health","author":"Gustafson","year":"2011"},{"issue":"6","key":"10.1016\/j.jsat.2019.04.001_bb0045","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1111\/add.12117","article-title":"Which elements of improvement collaboratives are most effective? A cluster-randomized trial","volume":"108","author":"Gustafson","year":"2013","journal-title":"Addiction"},{"key":"10.1016\/j.jsat.2019.04.001_bb0050","series-title":"Drug overdose deaths in the United States, 1999\u20132016. NCHS Data Brief, no 294. Hyattsville, MD: National Center for Health Statistics. 2017\/ CDC. Wide-ranging online data for epidemiologic research (WONDER)","author":"Hedegaard","year":"2016"},{"issue":"1","key":"10.1016\/j.jsat.2019.04.001_bb0055","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1111\/1475-6773.12093","article-title":"Adoption and diffusion of evidence-based addiction medications in substance abuse treatment","volume":"49","author":"Heinrich","year":"2014","journal-title":"Health Services Research"},{"issue":"1","key":"10.1016\/j.jsat.2019.04.001_bb0060","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.drugalcdep.2011.07.019","article-title":"Diversion and abuse of buprenorphine: Findings from national surveys of treatment patients and physicians","volume":"120","author":"Johanson","year":"2012","journal-title":"Drug and Alcohol Dependence"},{"key":"10.1016\/j.jsat.2019.04.001_bb0065","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.drugalcdep.2017.03.011","article-title":"Increases in prescription opioid injection abuse among treatment admissions in the United States, 2004\u20132013","volume":"176","author":"Jones","year":"2017","journal-title":"Drug and Alcohol Dependence"},{"issue":"446","key":"10.1016\/j.jsat.2019.04.001_bb0070","first-page":"699","article-title":"A RCT of three training and support strategies to encourage implementation of screening and brief alcohol intervention by general practitioners","volume":"49","author":"Kaner","year":"1999","journal-title":"The British Journal of General Practice"},{"issue":"4","key":"10.1016\/j.jsat.2019.04.001_bb0075","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.evalprogplan.2011.02.004","article-title":"Barriers to the implementation of medication-assisted treatment for substance use disorders: The importance of funding policies and medical infrastructure","volume":"34","author":"Knudsen","year":"2011","journal-title":"Evaluation and Program Planning"},{"issue":"1","key":"10.1016\/j.jsat.2019.04.001_bb0080","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1097\/ADM.0b013e3181d41ddb","article-title":"Adoption and implementation of medications in addiction treatment programs","volume":"5","author":"Knudsen","year":"2011","journal-title":"Journal of Addiction Medicine"},{"issue":"4","key":"10.1016\/j.jsat.2019.04.001_bb0085","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1097\/ADM.0b013e318262a97a","article-title":"Financial factors and the implementation of medications for treating opioid use disorders","volume":"6","author":"Knudsen","year":"2012","journal-title":"Journal of Addiction Medicine"},{"issue":"4","key":"10.1016\/j.jsat.2019.04.001_bb0090","doi-asserted-by":"crossref","first-page":"268","DOI":"10.7326\/M16-2149","article-title":"Primary care-based models for the treatment of opioid use disorder: A scoping review","volume":"166","author":"Korthuis","year":"2017","journal-title":"Annals of Internal Medicine"},{"key":"10.1016\/j.jsat.2019.04.001_bb0095","series-title":"The improvement guide: A practical approach to enhancing organizational performance","author":"Langley","year":"2009"},{"issue":"13","key":"10.1016\/j.jsat.2019.04.001_bb0100","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/1748-5908-1-13","article-title":"Innovations in mental health services implementation: A report on state-level data from the US Evidence-Based Practices Project","volume":"1","author":"Magnabosco","year":"2006","journal-title":"Implementation Science"},{"issue":"2","key":"10.1016\/j.jsat.2019.04.001_bb0105","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.drugalcdep.2006.10.009","article-title":"The Network for the Improvement of Addiction Treatment (NIATx): Enhancing access and retention","volume":"88","author":"McCarty","year":"2007","journal-title":"Drug and Alcohol Dependence"},{"key":"10.1016\/j.jsat.2019.04.001_bb0110","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1146\/annurev-publhealth-040617-013526","article-title":"Treatment and prevention of opioid use disorder: Challenges and opportunities","volume":"39","author":"McCarty","year":"2018","journal-title":"Annual Review of Public Health"},{"key":"10.1016\/j.jsat.2019.04.001_bb0115","doi-asserted-by":"crossref","DOI":"10.1186\/1748-5908-8-50","article-title":"Testing use of payers to facilitate evidence-based practice adoption: Protocol for a cluster-randomized trial","volume":"8","author":"Molfenter","year":"2013","journal-title":"Implementation Science"},{"issue":"1","key":"10.1016\/j.jsat.2019.04.001_bb0120","doi-asserted-by":"crossref","first-page":"11","DOI":"10.5963\/PHF0201002","article-title":"Development of a multilevel framework to increase use of targeted evidence-based practices in addiction treatment clinics","volume":"2","author":"Molfenter","year":"2013","journal-title":"Journal of Public Health Frontier"},{"issue":"1","key":"10.1016\/j.jsat.2019.04.001_bb0125","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/s13011-015-0009-2","article-title":"Implementing buprenorphine in addiction treatment: Payer and provider perspectives in Ohio","volume":"10","author":"Molfenter","year":"2015","journal-title":"Substance Abuse Treatment, Prevention, and Policy"},{"key":"10.1016\/j.jsat.2019.04.001_bb0135","unstructured":"Ohio Department of Health. (2014). 2014 Ohio preliminary drug overdose report. Columbus, OH. Available at http:\/\/www.healthy.ohio.gov\/~\/media\/HealthyOhio\/ASSETS\/Files\/injury prevention\/2014 Ohio Preliminary Overdose Report.pdf."},{"issue":"5051","key":"10.1016\/j.jsat.2019.04.001_bb0140","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.15585\/mmwr.mm655051e1","article-title":"Increases in drug and opioid-involved overdose deaths - United States, 2010\u20132015","volume":"65","author":"Rudd","year":"2016","journal-title":"MMWR. Morbidity and Mortality Weekly Report"},{"issue":"3","key":"10.1016\/j.jsat.2019.04.001_bb0145","doi-asserted-by":"crossref","first-page":"413","DOI":"10.15288\/jsad.2012.73.413","article-title":"Advancing recovery: Implementing evidence-based treatment for substance use disorders at the systems level","volume":"73","author":"Schmidt","year":"2012","journal-title":"Journal of Studies on Alcohol and Drugs"},{"issue":"5","key":"10.1016\/j.jsat.2019.04.001_bb0150","doi-asserted-by":"crossref","first-page":"917","DOI":"10.2105\/AJPH.2012.301049","article-title":"Opioid agonist treatments and heroin overdose deaths in Baltimore, Maryland, 1995\u20132009","volume":"103","author":"Schwartz","year":"2013","journal-title":"American Journal of Public Health"},{"issue":"1","key":"10.1016\/j.jsat.2019.04.001_bb0155","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1515\/1941-2851.1036","article-title":"A review of Ohio's treatment capacity in addressing the state's opiate epidemic","volume":"5","author":"Sherba","year":"2012","journal-title":"Journal of Drug Policy Analysis"},{"key":"10.1016\/j.jsat.2019.04.001_bb0160","author":"State of Wisconsin"},{"issue":"1","key":"10.1016\/j.jsat.2019.04.001_bb0165","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.jsat.2014.07.010","article-title":"Supply of buprenorphine waivered physicians: The influence of state policies","volume":"48","author":"Stein","year":"2015","journal-title":"Journal of Substance Abuse Treatment"},{"key":"10.1016\/j.jsat.2019.04.001_bb0170","author":"Substance Abuse and Mental Health Services Administration (SAMHSA)"},{"key":"10.1016\/j.jsat.2019.04.001_bb0175","author":"Substance Abuse and Mental Health Services Administration (SAMHSA)"},{"key":"10.1016\/j.jsat.2019.04.001_bb0180","unstructured":"Substance Abuse and Mental Health Services Administration (SAMHSA), Center for Behavioral Health Statistics and Quality. (2017). Treatment Episode Data Set (TEDS): 2005\u20132015. State admissions to substance abuse treatment services. Rockville, MD: Substance Abuse and Mental Health Services Administration. Available at https:\/\/www.samhsa.gov\/data\/sites\/default\/files\/2015 TEDS_State Admissions.pdf."},{"key":"10.1016\/j.jsat.2019.04.001_bb0185","author":"U.S. Department of Agriculture & Economic Research Service"},{"issue":"2","key":"10.1016\/j.jsat.2019.04.001_bb0190","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0054496","article-title":"Intertwined epidemics: National demographic trends in hospitalizations for heroin- and opioid-related overdoses, 1993\u20132009","volume":"8","author":"Unick","year":"2013","journal-title":"PLoS One"},{"issue":"22","key":"10.1016\/j.jsat.2019.04.001_bb0195","doi-asserted-by":"crossref","first-page":"2063","DOI":"10.1056\/NEJMp1402780","article-title":"Medication-assisted therapies\u2014Tackling the opioid-overdose epidemic","volume":"370","author":"Volkow","year":"2014","journal-title":"New England Journal of Medicine"},{"key":"10.1016\/j.jsat.2019.04.001_bb0205","author":"World Health Organization"}],"container-title":["Journal of Substance Abuse Treatment"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0740547218304264?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0740547218304264?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T19:49:23Z","timestamp":1760039363000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0740547218304264"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6]]},"references-count":39,"alternative-id":["S0740547218304264"],"URL":"https:\/\/doi.org\/10.1016\/j.jsat.2019.04.001","relation":{},"ISSN":["0740-5472"],"issn-type":[{"value":"0740-5472","type":"print"}],"subject":[],"published":{"date-parts":[[2019,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The payer's role in addressing the opioid epidemic: It's more than money","name":"articletitle","label":"Article Title"},{"value":"Journal of Substance Abuse Treatment","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jsat.2019.04.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}